Current and Former Awardees - Physician Scientists

Physician-Scientists

2025 Recipients

Annabelle J. Anandappa, MD

"The role of inflammatory signaling in the pathogenesis and therapeutic targeting of RAS-mutated AML" at Cincinnati Children's Hospital Medical Center

Charles S. Dai, MD

"Epigenetically targeting MYC through paradoxical nuclear receptor activation in hormone-dependent malignancies" at Massachusetts General Hospital

Alexandra E. Rojek, MD

"Leveraging memory-like T-cell phenotypes to improve cellular therapies" at The University of Chicago

2024 Recipients

Rahul S. Bhansali, MD

"Investigating chromatin architectural dynamics mediated by LDB1 in T-cell acute lymphoblastic leukemia" at University of Pennsylvania

Xiaoli Mi, MD

"Origin and evolution of long-lived CAR T cells in patients with hematologic malignancies" at Memorial Sloan Kettering Cancer Center

Vignesh Shanmugam, MD

"Uncovering microenvironmental dependencies in follicular lymphoma" at Brigham and Women's Hospital

Rebecca L. Zon, MD

"Defining the mechanism of thrombosis in patients with multiple myeloma" at Dana-Farber Cancer Institute

2023 Recipients

Nicole M. Cruz, MD

"Understanding the role of KMT2D in MLL-AF9 acute myeloid leukemia" at The Rockefeller University

Mounica Vallurupalli, MD

"Defining the mechanistic implications of SF3B1 mutations in MDS" at Dana-Farber Cancer Institute

Nina Weichert-Leahey, MD

"Elucidating the role of KAT6A and KAT6B in the epigenetic reprogramming of neuroblastoma to enforce neuronal differentiation" at Dana-Farber Cancer Institute

2022 Recipients

Wallace A. Bourgeois, MD

"Characterizing mechanisms of resistance to Menin inhibitors in KMT2A-rearranged and NPM1-mutant AML" at Dana-Farber Cancer Institute

Mark B. Leick, MD

"Engineering novel CAR T cells for AML: translating lessons from correlative studies and other diseases" at Massachusetts General Hospital

Mira A. Patel, MD

"Molecular mechanisms of human APOE-mediated myeloid cell modulation in cancer" at The Rockefeller University

2021 Recipients

Caitlin F. Bell, MD

"Smooth muscle cell plasticity in the tumor microenvironment: another parallel between atherosclerosis and cancer" at Stanford University School of Medicine

Albert E. Kim, MD

"Using liquid biopsy and MRI to non-invasively identify therapeutic targets for brain metastases" at Massachusetts General Hospital

2020 Recipients

Elisa A. Aquilanti, MD

"Targeting telomerase in glioblastoma" at Dana-Farber Cancer Institute

Dennis J. Hsu, MD

"Metabolic determinants of codon usage bias in colorectal cancer" at University of Pittsburgh

Andrew L. Ji, MD

"Cancer cell-extrinsic and intrinsic control of tumor progression and intratumoral heterogeneity" at Stanford University School of Medicine

2019 Recipients

Edmond M. Chan, MD

"Validating a novel synthetic lethal target for microsatellite unstable cancers" at Dana-Farber Cancer Institute

Andrew J. Dunbar, MD

"Interrogating functional contribution of JAK2V617F in the maintenance of myeloproliferative neoplasms" at Memorial Sloan Kettering Cancer Center

Gabriel K. Griffin, MD

"Enhancing cancer immunotherapy through epigenetic modulation of the repetitive genome" at Brigham and Women's Hospital

Jonathan E. Shoag, MD

"Harnessing clinical data to identify new prostate cancer therapeutics" at University Hospitals Cleveland Medical Center

Rabi Upadhyay, MD

"Determining the distal effects of gut microbiota on the lung tumor microenvironment, cancer progression, and checkpoint blockade efficacy" at NYU Grossman School of Medicine

2018 Recipients

Nicholas C. DeVito, MD

"Investigating the role of EMT-mediated dendritic cell tolerization in checkpoint inhibitor resistance" at Duke University

John R. Ferrarone, MD

"Seeking and evaluating novel therapeutic targets in human lung adenocarcinomas with loss-of-function mutations in LKB1" at Weill Cornell Medicine

Lillian M. Guenther, MD

"Investigation of CITED2 as a novel dependency in Ewing sarcoma" at St. Jude Children's Research Hospital

Harshabad Singh, MBBS

"Epigenetic evolution of pancreatic adenocarcinoma during combination chemotherapy" at Dana-Farber Cancer Institute

2017 Recipients

Christopher J. Gibson, MD

"The biology and clinical implications of clonal hematopoiesis in cancer patients" at Dana-Farber Cancer Institute

Sakiko Suzuki, MD

"Inflammatory cell death pathways in Myelodysplastic Syndromes" at University of Massachusetts Medical School

2016 Recipients

Kristopher R. Bosse, MD

"GPC2 as an oncogene and immunotherapeutic target in high-risk neuroblastoma" at Children's Hospital of Philadelphia

2015 Recipients

Carolyn C. Jackson, MD, MPH

"Genetic dissection of pediatric classic Kaposi sarcoma" at Memorial Sloan Kettering Cancer Center

Loretta S. Li, MD

"Mechanisms of disease and resistance in CRLF2-rearranged B-cell acute lymphoblastic leukemia" at Dana-Farber Cancer Institute